Diary - News
All news BIOCORP announces Partnership with AARDEX Group to Extend Smart Solutions for Precision Medication Adherence
Issoire (France), October 1st, 2020, at 07:30 am CEST - BIOCORP (FR0012788065 - ALCOR / Eligible PEA PME), a French company specialized in the design, development and manufacture of innovative medical devices, today announced an alliance with Belgium-based AARDEX Group, the world leader in medication adherence solutions.
This alliance is to combine BIOCORP’s connected add-on solutions for drug delivery devices with AARDEX’s proprietary Medication Event Monitoring System (MEMS®) and offer a comprehensive solution to patients and healthcare providers to effectively measure and manage medication adherence.
